Patients presenting with symptoms of the areas of interest embolisms, infection or inflammation, cardiometabolic (includes heart failure, cardiovascular disease, myocardial infarction, diabetes) and renal cohorts Other
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. 18 years of age or over 2. Willing and able to provide written informed consent and comply with study procedures 3. Subjects attending a definitive care team with research capabilities which has been enrolled in this collection study 4. The subject must present as one of the following cohorts: Group A – Embolism Cohort: Subjects presenting with symptoms indicative of thromboembolic events Group B – Infection or Inflammation Cohort: Subjects presenting with symptoms indicative of infection or inflammatory disorders Group C – Cardiometabolic Cohort: Subjects presenting with symptoms indicative of heart conditions such as cardiovascular disease, heart failure or acute coronary syndrome, or diabetes Group D – Renal Cohort: Subjects presenting with symptoms indicative of renal disorders Group E – Other Cohort: Subjects who are not eligible for any other groups
Exclusion criteria
Exclusion criteria: 1. <18 years of age 2. Vulnerable populations deemed inappropriate for the study by the sites Principal Investigator 3. Subjects who have previously been enrolled in the study within the past 3 months and re-entry would breach the 24 ml and or 6 fingerstick maximums
Countries
Scotland, United Kingdom